D
Decibel Bio
Crop epigenetic platform enhancing plant resilience and productivity through advanced biological programming
About Decibel Bio
Decibel Bio operates in the agricultural biotechnology sector, focusing on developing a crop epigenetic platform that enhances plant resilience and productivity. The company leverages a combination of biological, engineering, and data science expertise to transform agriculture, addressing the challenges posed by a volatile environment. By programming plant biology akin to software development, Decibel Bio enables the adaptation of crops to changing conditions, such as drought, by utilizing epigenetic and genetic data. This approach allows plants to imprint environmental adaptations onto their offspring, ensuring better survival and yield. The business model involves collaborating with industry leaders and securing financing from ventures like Breakthrough Energy Ventures and Future Ventures. Decibel Bio's target clients include agricultural companies and stakeholders interested in sustainable and efficient crop production. The company generates revenue through partnerships and licensing its technology to enhance crop traits and performance.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2024
- Headquarters
- Berkeley, United States
- Employees
- 13
- Open positions
- None listed
- Dealroom signal
- 49.9/100
- Industry
- Food
- Sub-industry
- AgriTech
- Sector
- Food, Biotechnology, Biotech and Pharma, Biotechnology in Food, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Mar 2025 | $12M | $48M | Leaps by Bayer · Syngenta Group Ventures · Breakthrough Energy Ventures · Future Ventures | ↗ |
Growth signals
Latest recorded traffic for Decibel Bio is 1.5K monthly website visits, up 15.4% over the last three months. Decibel Bio's team grew 30% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
Breakthrough Energy Ventures
Leaps by Bayer
Syngenta Group Ventures
Future Ventures
Other known investors1 additional known investor
Chan Zuckerberg Initiative
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Decibel Bio on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Decibel Bio’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







